Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Kerala HC Upholds Ban...

Kerala HC Upholds Ban on Misleading Discount Boards at Pharmacies

Written By : Susmita Roy Published On 2026-06-23T19:00:53+05:30  |  Updated On 23 Jun 2026 7:00 PM IST
Kerala HC Upholds Ban on Misleading Discount Boards at Pharmacies
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Kerala: The Kerala High Court has upheld a circular issued by the State Drugs Controller directing pharmacy licence applicants and licensees not to display discount boards containing misleading claims regarding medicine prices.

While dismissing petitions filed by pharmacy owners challenging the circular, the Court held that the licensing authority has the power to impose such conditions in the interest of protecting consumers from deceptive advertisements. At the same time, the Court clarified that there is no prohibition on selling medicines below the Maximum Retail Price (MRP) or offering genuine discounts.

The dispute arose from a Circular dated September 4, 2024, issued by the Office of the Drugs Controller. Through the circular, the Drugs Controller directed that applicants seeking grant or renewal of drug licences must submit an affidavit undertaking that they would not display discount boards at their pharmacies. The circular also required modification of the wording in the prescribed affidavit by replacing references to "misleading claims" with language relating to discount boards.

Two writ petitions were filed by pharmacy owners and medical shop operators challenging the circular and seeking its quashing. They also sought declarations that the Drugs Controller lacked authority to prevent pharmacies from displaying discount boards and that retailers were entitled to sell medicines below MRP and advertise such discounts. Meanwhile, a third petition was filed by a consumer seeking implementation of the circular, alleging that discount advertisements displayed by medical shops were misleading the public.

Also Read: Maharashtra FDA Cracks Down on Misleading Drug Claims, Seizes Medicines Worth Rs 73 Lakh

The petitioners argued that many pharmacies provide medicines at discounted prices by sacrificing part of their profit margins and maintain transparency by displaying booklets showing the medicines sold and the discounts offered. They contended that neither the Drugs and Cosmetics Act, 1940 nor the Drugs Rules, 1945, prohibits the sale of medicines below MRP or the public disclosure of discounts. According to them, the circular was therefore beyond the powers of the Drugs Controller and contrary to the statutory framework.

The pharmacy owners contended that the circular interfered with their right to conduct business and effectively restricted them from informing customers about discounts available on medicines. They submitted that the Drugs (Prices Control) Order only prohibits sale of medicines above the notified MRP and does not restrict retailers from selling drugs at lower prices. According to them, discount boards are an important means through which customers become aware of cheaper medicines and can make informed purchasing decisions. They argued that preventing display of such boards would indirectly discourage pharmacies from offering discounted medicines and would adversely affect consumers who benefit from lower prices. They also pointed out that several public-sector and government-supported pharmacy schemes advertise substantial discounts on medicines.

The petitioners further maintained that there was no statutory provision authorising the Drugs Controller to prohibit pharmacies from displaying discount boards. They argued that the circular imposed restrictions without legislative backing and therefore violated their legal and constitutional rights.

The petitioner in the connected case supporting the circular argued that many pharmacies prominently display boards claiming discounts of 50% to 60% or more on medicines, but such advertisements are often misleading. According to him, customers are attracted to these stores believing they will receive substantial discounts, only to discover later that either minimal discounts are offered or no meaningful discount is provided at all. He contended that such advertisements manipulate consumers and create a false impression regarding medicine prices. Therefore, he urged the Court to direct strict implementation of the circular and action against pharmacies violating its provisions.

The Drugs Controller defended the circular, stating that the department is responsible for implementing the Drugs and Cosmetics Act, the Drugs and Magic Remedies (Objectionable Advertisements) Act, and the Drugs Price Control Order. The State submitted that its objective was to eliminate unhealthy practices in the pharmaceutical trade and protect consumers from deceptive advertising.

The authorities clarified that they were not opposed to pharmacies offering discounts. In fact, they acknowledged that discounts make medicines more affordable for the public. However, their concern was with exaggerated and misleading discount advertisements that claim discounts of up to 80% and attract customers through false representations. The State maintained that while retailers are free to sell medicines below MRP, they cannot mislead consumers through vague or exaggerated discount claims.

The State further contended that under the Drugs Price Control Order, retailers are required to display manufacturer-supplied price lists rather than generic discount boards. According to the authorities, some customers were being misled into believing they were receiving major discounts while ultimately paying close to the MRP. The circular was therefore intended as a practical reform measure to ensure transparency and prevent exploitation of consumers. The department also informed the Court that it had decided to rephrase the undertaking required from licensees and had not initiated any punitive action so far.

After examining the statutory provisions, the Court observed that the Drugs Price Control Order clearly prohibits sale of medicines above the MRP but does not restrict retailers from selling medicines at lower prices. Therefore, pharmacies are legally entitled to offer discounts and reduced prices to consumers. However, the Court noted that the circular does not prohibit discounts; rather, it seeks to prevent misleading advertisements relating to discounts.

The Court held that regulatory authorities must act within the framework of law, but they also possess incidental powers necessary to effectively discharge their statutory functions. According to the Court, the licensing authority is entitled to impose conditions while granting or renewing licences if those conditions are intended to protect the public from misleading practices. Since discount advertisements have the potential to deceive customers, the authority was justified in requiring licensees to provide an undertaking against such conduct.

The Court further observed that constitutional freedoms and business rights cannot be used as shields for practices that may harm consumers. It emphasised that regulatory authorities are entitled to a degree of flexibility or "play in the joints" when framing measures to protect public interest. Judicial interference is unwarranted unless such regulatory directions severely curtail business rights without any corresponding public benefit. Considering the significant role played by the Drugs Controller in regulating drug licensing, the Court found no reason to interfere with the circular.

Also Read: NPPA Grants 50% Ceiling Price Hike for Anti-Tetanus Immunoglobulin Injections

The Court also took note of the revised undertaking proposed by the department, which reads:

"We undertake that we shall not display any discount boards containing misleading or vague claims regarding the price of drugs"

According to the Court, this revised condition does not prejudice the rights of pharmacy owners and merely obliges them to avoid misleading consumers.

Upholding the validity of the Drugs Controller's action, the Court concluded:

"Taking note of the above circumstances, this Court is of the view that the power of the licensing authority to stipulate certain conditions while submitting applications for the grant of a licence cannot be said to be arbitrary or warranting an interference by this Court."

The Court further ordered:

"Hence W.P.(C) No. 39706 of 2024 and W.P.(C) No.41978 of 2024 are dismissed, while W.P.(C) No.1447 of 2025 is allowed as above."

To view the order, click the link below:

https://medicaldialogues.in/pdf_upload/2026/06/23/pharmadude-v-state-of-kerala-1779792-355789.pdf
kerala high courtpharmacy discount boardsmisleading advertisementsdrugs controllerdrug licencepharmacy licencemedicine discountsdiscount advertisementsretail pharmaciesdeceptive marketingmisleading claimsban

Medical Survey

Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Print Article
    Show Full Article
    Next Story
    Recommended For You
    NO DATA FOUND

    Editorial

    Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

    Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians

    Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev Joshi

    Jural Exploitation of Healthcare Professionals and Institutions in the PM-RAHAT Scheme - Dr Rajeev...

    Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

    Metformin - Eight Points on a Metabolic Anchor in T2D: World Diabetes Day Special

    Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination - Dr. Makarand Damle

    Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination...

    Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

    Effect of Saroglitazar in MASLD: Latest Indian 2026 Study

    View All

    Journal Club Today

    Muscle Loss or Water Loss? Researchers Examine Effects of Ketogenic Diets on Body Composition

    Muscle Loss or Water Loss? Researchers Examine Effects of Ketogenic Diets on Body Composition

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok